Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Transplant International : Official Journal of the European Society for Organ Transplantation|December 14, 2023
The Yield of Routine Post-Operative Doppler Ultrasound to Detect Early Post-Liver Transplantation Vascular ComplicationsIulia Minciuna, Caroline den Hoed, Adriaan J van der Meer, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 21, 2018
Dichotomal functions of phosphorylated and unphosphorylated STAT1 in hepatocellular carcinomaBuyun Ma, Kan Chen, Pengyu Liu, et al.
Molecular Medicine (Cambridge, Mass.)|October 16, 2015
Differential Sensitivities of Fast- and Slow-Cycling Cancer Cells to Inosine Monophosphate Dehydrogenase 2 Inhibition by Mycophenolic AcidKan Chen, Wanlu Cao, Juan Li, et al.
European Journal of Gastroenterology & Hepatology|May 17, 2019
Immunosuppressive drug withdrawal late after liver transplantation improves the lipid profile and reduces infectionsAafke A Duizendstra, Robert J de Knegt, Michiel G H Betjes, et al.
Pharmaceuticals (Basel, Switzerland)|January 13, 2021
Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular CarcinomaKoen G A M Hussaarts, Leni van Doorn, Sander Bins, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 11, 2026
Clinical utility and diagnostic accuracy of the GAAD score in non-cirrhotic patients with focal liver lesionsMohamed Moussa, Dave Sprengers, Vera Ketting, et al.
Clinical and Translational Radiation Oncology|November 8, 2024
Long-term outcomes of more than a decade treating patients with stereotactic body radiation therapy for hepatocellular carcinomaWilhelm den Toom, Eva M Negenman, Francois E J A Willemssen, et al.
Antiviral Therapy|October 9, 2009
Alpha-galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trialAndrea M Woltman, Martijn J Ter Borg, Rekha S Binda, et al.
British Journal of Cancer|February 20, 2020
HHLA2 is expressed in pancreatic and ampullary cancers and increased expression is associated with better post-surgical prognosisPatrick P C Boor, Kostandinos Sideras, Katharina Biermann, et al.
Oncoimmunology|November 21, 2015
GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cells <i>ex vivo</i>Alexander Pedroza-Gonzalez, Guoying Zhou, Simar Pal Singh, et al.
Pageof 9